Logo image of CHSCM

CHS INC - CHSINC 6 3/4 PERP (CHSCM) Stock Fundamental Analysis

NASDAQ:CHSCM - Nasdaq - US12542R7044 - Currency: USD

24.3  -0.27 (-1.12%)

Fundamental Rating

5

Overall CHSCM gets a fundamental rating of 5 out of 10. We evaluated CHSCM against 88 industry peers in the Food Products industry. CHSCM has an excellent profitability rating, but there are some minor concerns on its financial health. CHSCM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

CHSCM had a positive operating cash flow in the past year.
CHSCM had positive earnings in each of the past 5 years.
Each year in the past 5 years CHSCM had a positive operating cash flow.
CHSCM Yearly Net Income VS EBIT VS OCF VS FCFCHSCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 7.92%, CHSCM belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
CHSCM has a Return On Equity of 14.11%. This is in the better half of the industry: CHSCM outperforms 78.41% of its industry peers.
CHSCM has a Return On Invested Capital of 5.88%. This is in the better half of the industry: CHSCM outperforms 61.36% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHSCM is below the industry average of 9.00%.
The 3 year average ROIC (5.40%) for CHSCM is below the current ROIC(5.88%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROIC 5.88%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
CHSCM Yearly ROA, ROE, ROICCHSCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

With a decent Profit Margin value of 3.62%, CHSCM is doing good in the industry, outperforming 62.50% of the companies in the same industry.
In the last couple of years the Profit Margin of CHSCM has grown nicely.
With a Operating Margin value of 2.42%, CHSCM perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
CHSCM's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 5.06%, CHSCM is not doing good in the industry: 82.95% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CHSCM has grown nicely.
Industry RankSector Rank
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
CHSCM Yearly Profit, Operating, Gross MarginsCHSCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 1 2 3 4 5

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHSCM is still creating some value.
CHSCM has a better debt/assets ratio than last year.
CHSCM Yearly Shares OutstandingCHSCM Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCM Yearly Total Debt VS Total AssetsCHSCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

CHSCM has an Altman-Z score of 2.82. This is not the best score and indicates that CHSCM is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.82, CHSCM is doing good in the industry, outperforming 64.77% of the companies in the same industry.
CHSCM has a debt to FCF ratio of 1.02. This is a very positive value and a sign of high solvency as it would only need 1.02 years to pay back of all of its debts.
The Debt to FCF ratio of CHSCM (1.02) is better than 89.77% of its industry peers.
CHSCM has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.19, CHSCM is doing good in the industry, outperforming 68.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Altman-Z 2.82
ROIC/WACC1.03
WACC5.69%
CHSCM Yearly LT Debt VS Equity VS FCFCHSCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B 10B

2.3 Liquidity

CHSCM has a Current Ratio of 1.58. This is a normal value and indicates that CHSCM is financially healthy and should not expect problems in meeting its short term obligations.
CHSCM's Current ratio of 1.58 is in line compared to the rest of the industry. CHSCM outperforms 56.82% of its industry peers.
A Quick Ratio of 0.91 indicates that CHSCM may have some problems paying its short term obligations.
CHSCM has a Quick ratio (0.91) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.91
CHSCM Yearly Current Assets VS Current LiabilitesCHSCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

1

3. Growth

3.1 Past

The Revenue for CHSCM has decreased by -17.09% in the past year. This is quite bad
The Revenue has been growing slightly by 6.88% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCM Yearly Revenue VS EstimatesCHSCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCM Price Earnings VS Forward Price EarningsCHSCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHSCM is valued cheaply inside the industry as 98.86% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than CHSCM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.14
EV/EBITDA 0.95
CHSCM Per share dataCHSCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1K 2K 3K

4.3 Compensation for Growth

CHSCM has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

CHSCM has a Yearly Dividend Yield of 7.41%, which is a nice return.
CHSCM's Dividend Yield is rather good when compared to the industry average which is at 4.36. CHSCM pays more dividend than 92.05% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.52, CHSCM pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.41%

5.2 History

CHSCM has paid a dividend for at least 10 years, which is a reliable track record.
CHSCM has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
CHSCM Yearly Dividends per shareCHSCM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

11.11% of the earnings are spent on dividend by CHSCM. This is a low number and sustainable payout ratio.
DP11.11%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCM Yearly Income VS Free CF VS DividendCHSCM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B
CHSCM Dividend Payout.CHSCM Dividend Payout, showing the Payout Ratio.CHSCM Dividend Payout.PayoutRetained Earnings

More info and screens

CHS INC - CHSINC 6 3/4 PERP

NASDAQ:CHSCM (4/17/2025, 8:08:57 PM)

24.3

-0.27 (-1.12%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-01 2025-04-01
Earnings (Next)07-08 2025-07-08
Inst Owners13.41%
Inst Owner Change0%
Ins Owners0.03%
Ins Owner Change0%
Market Cap298.16M
Analysts0
Price TargetN/A
Short Float %0.17%
Short Ratio0.86
Dividend
Industry RankSector Rank
Dividend Yield 7.41%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP11.11%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-13 2025-06-13 (0.421875)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.14
P/OCF 0.1
P/B 0.03
P/tB 0.03
EV/EBITDA 0.95
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)178.98
FCFY736.55%
OCF(TTM)233.94
OCFY962.7%
SpS3422.59
BVpS877.08
TBVpS877.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROCE 7.68%
ROIC 5.88%
ROICexc 6.17%
ROICexgc 6.17%
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
FCFM 5.23%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
ROICexc(3y)5.96%
ROICexc(5y)4.73%
ROICexgc(3y)6.08%
ROICexgc(5y)4.81%
ROCE(3y)7.21%
ROCE(5y)6.02%
ROICexcg growth 3Y73.02%
ROICexcg growth 5Y27.66%
ROICexc growth 3Y72.21%
ROICexc growth 5Y27.52%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
F-Score6
Asset Turnover2.19
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Debt/EBITDA 1.33
Cap/Depr 122.19%
Cap/Sales 1.61%
Interest Coverage 250
Cash Conversion 182.9%
Profit Quality 144.65%
Current Ratio 1.58
Quick Ratio 0.91
Altman-Z 2.82
F-Score6
WACC5.69%
ROIC/WACC1.03
Cap/Depr(3y)76.68%
Cap/Depr(5y)79.95%
Cap/Sales(3y)0.94%
Cap/Sales(5y)1.13%
Profit Quality(3y)105.8%
Profit Quality(5y)111.96%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.39%
EBIT growth 3Y69.09%
EBIT growth 5Y26.62%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y620.74%
FCF growth 3Y59.62%
FCF growth 5Y30.48%
OCF growth 1Y387.5%
OCF growth 3Y44.56%
OCF growth 5Y25.04%